Case study: cypath® lung detects stage 1a lung cancer in high-risk patient with inconclusive imaging and low-risk serum test results

San antonio--(business wire)-- #biaf--cypath® lung detects a rare mucinous adenocarcinoma at stage 1a in a high-risk individual whose previous tests suggested a low probability of cancer.

BIAF Ratings Summary

BIAF Quant Ranking